-
-
-
-
-
-
-
BBOT publishes preclinical data on panKRAS inhibitor BBO-11818
-
-
-
-
-
-
-
Morgan Stanley on BridgeBio Oncology Therapeutics, In (BBOT): 'Strong efficacy and tolerability for BBO-8520'
-
-
-
-
-
-
-
Wedbush Reiterates Outperform Rating on BridgeBio Oncology Therapeutics, In (BBOT)
-
-
459,501 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

